Patient Perspective
- PMID: 36942367
- DOI: 10.1002/mds.29361
Patient Perspective
References
Reference
-
- Kingwell K. LRRK2-Targeted Parkinson's Drug Advances into Phase III. London, UK: Nature Reviews Drug Discovery; 2022.
Publication types
LinkOut - more resources
Full Text Sources
